Efficacy and Safety of Low-Dose Rituximab in Anti-MuSK Myasthenia Gravis Patients: A Retrospective Study

Efficacy and Safety of Low-Dose Rituximab in Anti-MuSK Myasthenia Gravis Patients: A Retrospective Study

Xin Meng,1 Ziling Zeng,2 Yunda Wang,3 Shuai Guo,1 Chunjuan Wang,2 Baojie Wang,1 Shougang Guo1,2 1Department of Neurology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of China; 2Department of Neurology, Shandong Provincial Hospita...

Full description

Bibliographic Details
Main Authors: Meng X, Zeng Z, Wang Y, Guo S, Wang C, Wang B
Format: Article
Language:English
Published: Dove Medical Press 2022-05-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
myasthenia gravis
rituximab
low-dose
muscle-specific kinase
Online Access:https://www.dovepress.com/efficacy-and-safety-of-low-dose-rituximab-in-anti-musk-myasthenia-grav-peer-reviewed-fulltext-article-NDT

Internet

https://www.dovepress.com/efficacy-and-safety-of-low-dose-rituximab-in-anti-musk-myasthenia-grav-peer-reviewed-fulltext-article-NDT

Similar Items